We provide Targeted therapy drug Imatinib Mesylate ( Gleevec ) to Philadelphia Chromosome positive Chronic Myeloid Leukemia ( CML ) & Acute Lymphoblastic Leukemia ( ALL ) and CD 117 positive Gastrointestinal Stromal Tumor ( GIST ) with Curative Intention. At present we provide lifelong free of cost this noble & expensive medicine to 358 CML, 5 ALL & 28 GIST patients with generous donation from Max Foundation USA. We also provide lifelong free supply of Targeted therapy drug Sunitinib Malate (Sutent) for treatment of Metastatic Renal Cell Carcinoma ( MRCC ) & Gleevec resistant GIST with generous help from Axios Health Care Development, USA. At present we have 59 patients of MRCC &3 patients of GIST receiving lifelong this noble & very expensive medicine. Occasionally we receive plenty of cancer Drugs as a generous gift from abroad including China.